Skip to main content
. Author manuscript; available in PMC: 2010 Feb 15.
Published in final edited form as: Circ Res. 2008 Dec 18;104(3):403–411. doi: 10.1161/CIRCRESAHA.108.190918

Figure 6.

Figure 6

eNOS mediates metformin-induced cardioprotection. (A) LVEDD, (B) LVESD and (C) Ejection Fraction (EF) and (D) H/BW ratios was measured at baseline and following myocardial ischemia in eNOS deficient mice ± daily metformin therapy. Values are means ± S.E.M. Numbers inside bars indicate the number of animals that were investigated in each group. *** p < 0.001 vs. Baseline, * p < 0.05 vs. Sham. Veh = vehicle, Met QD = Metformin QD.